abnormal immune tolerance_Tg(TcraY1,TcrbY1)416Tev/0

http://metadb.riken.jp/0005000IC57BL6JDBA2JTgTcraY1TcrbY1416Tev0TgTcraY1TcrbY1416Tev

abnormal immune tolerance_Tg(TcraY1,TcrbY1)416Tev/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 416, Satvir S Tevethia
  http://metadb.riken.jp/db/mgi_rdf/MGI:3700738

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(TcraY1,TcrbY1)416Tev/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(TcraY1,TcrbY1)416Tev

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J * DBA/2J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal immune tolerance
  http://purl.obolibrary.org/obo/MP_0005000

文献

http://purl.org/net/cito/citesAsAuthority

• Kevin. Staveley-O'Carroll, et.al., In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice., Journal of immunology (Baltimore, Md. : 1950), 2003, 171
  http://rdf.ncbi.nlm.nih.gov/pubmed/12847236